PATHOGENESIS AND TREATMENT OF ALTERED BLOOD COAGULABILITY IN PATIENTS WITH MALIGNANT TUMORS*
- 1 March 1974
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 230 (1) , 289-293
- https://doi.org/10.1111/j.1749-6632.1974.tb14460.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The fibrinogenolytic pathway of fibrinogen catabolismThrombosis Research, 1973
- Platelet and Fibrinogen Consumption in ManNew England Journal of Medicine, 1972
- Pathology of disseminated intravascular coagulation (DIC)Human Pathology, 1972
- Metabolism and Distribution of Fibrinogen. I. FIBRINOGEN TURNOVER IN PHYSIOLOGICAL CONDITIONS IN HUMANSBritish Journal of Haematology, 1972
- Activated Coagulation Factors: In-Vivo and in-Vitro StudiesBritish Journal of Haematology, 1969
- The Defibrination Syndrome: Clinical Features and Laboratory DiagnosisBritish Journal of Haematology, 1967
- The Preparation and Properties of Human Fibrinogen of Relatively High Solubility*Biochemistry, 1966
- Hypercoagulability Associated with Malignant Disease and with the Postoperative StateAnnals of Internal Medicine, 1963
- Cofibrins and Fibrin-Intermediates as Indicators of Thrombin Activity in VivoCirculation Research, 1960
- Fibrinolysis and Fibrinolytic Activity in ManPhysiological Reviews, 1959